Indeed, it was previously shown that inhibition of BCAT1 and BCAT2 did not impair tumor growth in PDAC, despite resulting in inhibited tumorigenesis in nonsmall cell lung cancer—indicating that tissue of origin is determinative of selective and differential pathways for BCAA and glutamine metabolism among cancer types.66 This evidence concerns the gene ARID4B and lung cancer.